Taztia XT(diltiazem HCI extended release capsules, USP, Once-A-Day Dosage, 360 mg, 90 Capsules per bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, Distributed by: Watson Pharma, NDC 62037-700-90.
Published February 13, 2013 · Recall initiated: December 18, 2012
Summary
FDA records drug Class II recall D-145-2013, published February 13, 2013 and initiated December 18, 2012. Recalling firm: Watson Pharmaceuticals; Status: Terminated; Reported quantity: 3,040 bottles; Lot: Lot #: 512146A, Exp 01/31/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specification: Out of a specification result occurred during the 3-month stability testing. Dissolution result at the 4-hour time point was 41% (specification: 20-40%).
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Watson Pharmaceuticals
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: 512146A, Exp 01/31/2014
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMethocarbamol 750 mg Tablets, 90-count bottle, Mfg by: West-Ward Pharm. Corp., Eatontown, NJ 07724, PackagedFebruary 13, 2013
- FDAEstroGel (estradiol gel) 0.06%, contained in 50-gr metered pumps, 1.25g/pump depression, for use as physicianFebruary 13, 2013
- FDAVentavis (iloprost) Inhalation Solution, 10 mcg/1 mL, Sterile, 30 Single Use Ampules per carton, ManufacturedFebruary 13, 2013
- FDALansoprazole Delayed-release Capsules, USP, 30 mg, 500-count capsules per bottle, Rx only, Manufactured for:February 13, 2013
- FDASLIM XTREME Herbal Slimming Capsule, supplied in 30-count bottles. Another Product Forumulated and DistributedFebruary 13, 2013
- FDAInfinity Enteralite Ambulatory Feeding Pumps, List number: INFKIT2 - Addendum to Operator's Manual ProductFebruary 6, 2013
Questions about this recall
Was Taztia XT(diltiazem HCI extended release capsules, USP, Once-A-Day Dosage, 360 mg, 90 Capsules per bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, Distributed by: Watson Pharma, NDC 62037-700-90. recalled?
Yes. FDA published recall D-145-2013 on February 13, 2013. Reported hazard: Failed Dissolution Specification: Out of a specification result occurred during the 3-month stability testing. Dissolution result at the 4-hour time point was 41% (specification: 20-40%).
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail